I. Kloots

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

Derya Yakar, J. Fütterer, R. V. D. van den Bergh, 2023, European urology open science.

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

J. Schalken, H. Bloemendal, M. Smits, 2021, British Journal of Cancer.

Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate Cancer

E. Willscher, M. Smits, I. V. van Oort, 2020 .

Impact of DNA damage repair defects and aggressive variant features on response to carboplatin‐based chemotherapy in metastatic castration‐resistant prostate cancer

J. Schalken, M. Ligtenberg, H. Bloemendal, 2020, International journal of cancer.

Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer

J. Schalken, H. Bloemendal, I. V. van Oort, 2023, Cancers.

Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer.

J. Schalken, A. G. van der Heijden, T. Smilde, 2023, European urology oncology.